Cardiac Ablation Devices – Pipeline Products by Stage of Development 16
Cardiac Ablation Devices – Pipeline Products by Territory 17
Cardiac Ablation Devices – Pipeline Products by Regulatory Path 18
Cardiac Ablation Devices – Pipeline Products by Estimated Approval Date 19
Cardiac Ablation Devices – Ongoing Clinical Trials 20
Cardiac Ablation Devices Companies – Pipeline Products by Stage of Development 21
Cardiac Ablation Devices – Pipeline Products by Stage of Development 24
Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview 27
Volt Pulsed Field Ablation System – Product Status 27
Volt Pulsed Field Ablation System – Product Description 27
Abbott Medical – Ongoing Clinical Trials Overview 28
Volt Pulsed Field Ablation System – A Pre-market, Multi-centered Clinical Study to Evaluate the Safety and Effectiveness of Volt Pulsed Field Ablation System 29
AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
AutoBlator – Product Status 30
AutoBlator – Product Description 30
CircumBlator AF Catheter Ablation System – Product Status 30
CircumBlator AF Catheter Ablation System – Product Description 31
AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
PFA Pulsed Electric Field Ablation System – Product Status 32
PFA Pulsed Electric Field Ablation System – Product Description 32
AccuPulse Medical Technology Co Ltd – Ongoing Clinical Trials Overview 33
PFA Pulsed Electric Field Ablation System – Feasibility and Safety Evaluation of the Pulsed Electric Field Ablation System on Patients with Chronic Bronchitis 34
Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35
AcQBlate Force Sensing Ablation Catheter – Product Status 35
AcQBlate Force Sensing Ablation Catheter – Product Description 35
Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
iCLAS System – Product Status 36
iCLAS System – Product Description 36
PFCA (Pulsed Field Cryoablation) System – Product Status 37
PFCA (Pulsed Field Cryoablation) System – Product Description 37
Adagio Medical Inc. – Ongoing Clinical Trials Overview 38
iCLAS System – A First-in-human Study of Pulsed Field Cryoablation for the Treatment of Patients with Atrial Fibrillation 39
iCLAS System – Cryoablation for Monomorphic Ventricular Tachycardia 39
iCLAS System – Cryoablation for Monomorphic Ventricular Tachycardia Early Feasibility Study (EFS) 39
iCLAS System – iCLAS Cryoablation System Post-Market Clinical Follow-up (PMCF) Study 39
iCLAS System – iCLAS for Persistent Atrial Fibrillation 40
iCLAS System – PARALELL – Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation 40
PFCA (Pulsed Field Cryoablation) System – PARALELL – Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation 41
Affera Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Affera Mapping and Ablation System – Product Status 42
Affera Mapping and Ablation System – Product Description 42
HexaGEN Ablation System – Product Status 43
HexaGEN Ablation System – Product Description 43
Sphere9 Catheter – Product Status 43
Sphere9 Catheter – Product Description 43
SpherePVI – Product Status 44
SpherePVI – Product Description 44
Affera Inc – Ongoing Clinical Trials Overview 45
Sphere9 Catheter – Study to Evaluate the Safety and Efficacy of Lattice Sphere Catheter to Reduce Complication Risk During Cardiac Ablation 46
Affera Mapping and Ablation System – First-in-human Study Evaluating the Safety and Effectiveness of the SpherePVI Catheter and Affera System in Patients with Atrial Fibrillation 47
Affera Mapping and Ablation System – The Affera Global Registry Is A Prospective, Global, Multi-center, Observational Post-Market Registry (PMR) 47
Affera Mapping and Ablation System – Treatment of Persistent Atrial Fibrillation with the Sphere-9 Mapping and Ablation Catheter and the Affera Mapping and Ablation System 47
SpherePVI – A Safety and Performance Assessment of the Affera SpherePVI Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation 48
SpherePVI – A Safety and Performance Assessment of the SpherePVI Catheter and the Affera Mapping and Ablation System to Treat Paroxysmal Atrial Fibrillation 48
SpherePVI – First-in-human Study Evaluating the Safety and Effectiveness of the SpherePVI Catheter and Affera System in Patients with Atrial Fibrillation 48
AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
Tip-Catheter – Product Status 49
Tip-Catheter – Product Description 49
AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Non-Thermal Vein Ablation Device – Product Status 50
Non-Thermal Vein Ablation Device – Product Description 50
APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Pulse Ablation Generator – Product Status 51
Pulse Ablation Generator – Product Description 51
Ring Pulse Ablation Catheter – Product Status 51
Ring Pulse Ablation Catheter – Product Description 52
Arga Medtech SA Pipeline Products & Ongoing Clinical Trials Overview 53
Coherent Sine-Burst Electroporation Ablation System – Product Status 53
Coherent Sine-Burst Electroporation Ablation System – Product Description 53
Non-Thermal Cardiac Ablation System – Product Status 53
Non-Thermal Cardiac Ablation System – Product Description 54
Arga Medtech SA – Ongoing Clinical Trials Overview 55
Coherent Sine-Burst Electroporation Ablation System – An IDE Study Coherent Sine-Burst Pulsed Field Ablation (PFA) System in Treatment of Atrial Fibrillation 56
Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
mPEF Device – Atrial Fibrillation – Product Status 57
mPEF Device – Atrial Fibrillation – Product Description 57
AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 58
AtriCure Bipolar System – Product Status 58
AtriCure Bipolar System – Product Description 58
AtriCure Isolator Synergy Surgical Ablation System – Inappropriate Sinus Tachycardia (IST) – Product Status 59
AtriCure Isolator Synergy Surgical Ablation System – Inappropriate Sinus Tachycardia (IST) – Product Description 59
AtriCure Inc – Ongoing Clinical Trials Overview 60
AtriCure Bipolar System – Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation 61
Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Satera Ablation System – Product Status 62
Satera Ablation System – Product Description 62
Axon Therapies Inc – Ongoing Clinical Trials Overview 63
Satera Ablation System – Endovascular Ablation of the Right Greater Splanchnic Nerve in Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF: Feasibility Study: Randomized Controlled Feasibility Trial – Rebalance-HF Study 64
Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Cardiac Ablation Mitigating Device – Product Status 65
Cardiac Ablation Mitigating Device – Product Description 65
Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Omnypulse Bi-Directional Catheter – Product Status 66
Omnypulse Bi-Directional Catheter – Product Description 66
VARIPULSE Catheter – Product Status 67
VARIPULSE Catheter – Product Description 67
VARIPULSE Platform – Product Status 67
VARIPULSE Platform – Product Description 67
Biosense Webster Inc – Ongoing Clinical Trials Overview 69
VARIPULSE Catheter – Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation with the BWI IRE Ablation System (AdmIRE) 70
VARIPULSE Catheter – Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy 70
Omnypulse Bi-Directional Catheter – Safety and Effectiveness Evaluation of the OMNYPULSE Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF) 71
Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 72
HeArTPAD – Product Status 72
HeArTPAD – Product Description 72
Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 73
Cardiac Sympathetic Denervation Device – Product Status 73
Cardiac Sympathetic Denervation Device – Product Description 73
CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 74
ICEolate Catheter – Product Status 74
ICEolate Catheter – Product Description 74
ICEolate Catheter With Spot Ablation Tip – Product Status 75
ICEolate Catheter With Spot Ablation Tip – Product Description 75
ICEolate Surgical Probe With Control Handle – Product Status 75
ICEolate Surgical Probe With Control Handle – Product Description 75
ICEolate Surgical Probe With Flexible Ablation Tip – Product Status 76
ICEolate Surgical Probe With Flexible Ablation Tip – Product Description 76
Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
Cryo-RDN System – Product Status 77
Cryo-RDN System – Product Description 77
Pulmonary Hypertension Cryoablation System – Product Status 77
Pulmonary Hypertension Cryoablation System – Product Description 78
CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview 79
CyberHeart System – Product Status 79
CyberHeart System – Product Description 79
ElectroPhysiology Frontiers S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 80
Fiore Catheter – Product Status 80
Fiore Catheter – Product Description 80
Epiendoaf Inc Pipeline Products & Ongoing Clinical Trials Overview 81
EpiEndoAF Device – Product Status 81
EpiEndoAF Device – Product Description 81
Field Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 82
FieldForce Ablation System – Product Status 82
FieldForce Ablation System – Product Description 82
Field Medical Inc – Ongoing Clinical Trials Overview 83
FieldForce Ablation System – A Pre-Market, First-In-Human, Pilot, Interventional, Clinical Investigation to Evaluate Safety and Feasibility of the FieldForce™ Ablation System in Symptomatic Patients With Ventricular Arrhythmia 84
Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 85
Centauri System – Product Status 85
Centauri System – Product Description 85
Galaxy Medical Products Inc – Ongoing Clinical Trials Overview 86
Centauri System – Study Evaluating the Safety and Efficacy of the Centauri system (ECLIPSE-AF) 87
Centauri System – Study Evaluating the Safety and Efficacy of the Centauri System in Patients with Persistent Atrial Fibrillation: SPACE-AF 87
Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 88
Qualiblate – Product Status 88
Qualiblate – Product Description 88
Hangzhou Nuocheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
Liwen RF Ablation System – Product Status 89
Liwen RF Ablation System – Product Description 89
Hangzhou Nuocheng Medical Technology Co Ltd – Ongoing Clinical Trials Overview 90
Liwen RF Ablation System – Confirmatory Clinical Study of Liwen RF Ablation System 91
Hangzhou Nuomao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 92
CardioPulse Field Ablation System – Product Status 92
CardioPulse Field Ablation System – Product Description 92
Hangzhou Nuomao Medical Technology Co Ltd – Ongoing Clinical Trials Overview 93
CardioPulse Field Ablation System – An Exploratory Study of Focal Pulse Ablation System in the Treatment of Typical Atrial Flutter 94
CardioPulse Field Ablation System – First in Man Study to Evaluate Safety and Efficacy of Left Atrial Appendage Pulsed Field Ablation Occluder for Simultaneous Pulsed Field Ablation and Mechanical Closure of the Left Atrial Appendage in Patients With Nonvalvular Atrial Fibrillation 94
CardioPulse Field Ablation System – The Effectiveness and Safety of CardioPulse Pulse Ablation System in the Treatment of Paroxysmal Atrial Fibrillation 94
Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95
Catheter-Based Ablation Device – Product Status 95
Catheter-Based Ablation Device – Product Description 95
Huifeng Biotechnology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
Atrial Fibrillation Pulsed Field Ablation System – Product Status 96
Atrial Fibrillation Pulsed Field Ablation System – Product Description 96
Insight Lifetech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 97
Pulsed Field Ablation Catheter – Product Status 97
Pulsed Field Ablation Catheter – Product Description 97
Pulsed Field Ablation System – Product Status 97
Pulsed Field Ablation System – Product Description 98
Insight Lifetech Co Ltd – Ongoing Clinical Trials Overview 99
Pulsed Field Ablation System – A Prospective, Multicenter, Randomized, and Controlled Study of Pulsed Field Ablation System 100
Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 101
Catheter Guiding Computational Modeling Tool – Product Status 101
Catheter Guiding Computational Modeling Tool – Product Description 101
Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 102
CHS – Coated Globe Mapping And Ablation System – Product Status 102
CHS – Coated Globe Mapping And Ablation System – Product Description 102
Globe Mapping And Ablation System – Product Status 103
Globe Mapping And Ablation System – Product Description 103
Globe PF System – Product Status 103
Globe PF System – Product Description 104
Kardium Inc – Ongoing Clinical Trials Overview 105
Globe Mapping And Ablation System – An Investigational Clinical Study of Globe Mapping and Ablation System in Treatment of Patients with Atrial Fibrillation 106
Globe Mapping And Ablation System – PULSE-EU – A Prospective, Non-randomized Clinical Pilot Study to Assess Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation 106
Globe PF System – A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe Pulsed Field System for Treating Patients with Symptomatic Paroxysmal or Persistent Atrial Fibrillation 107
LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 108
OmniView Light-Guided Ablation Catheter – Product Status 108
OmniView Light-Guided Ablation Catheter – Product Description 108
LuxMed Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 109
Next Generation Percutaneous Catheter – Product Status 109
Next Generation Percutaneous Catheter – Product Description 109
Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 110
Cardioblate Irrigated RF (IRF) System – Non-Paroxysmal Atrial Fibrillation – Product Status 110
Cardioblate Irrigated RF (IRF) System – Non-Paroxysmal Atrial Fibrillation – Product Description 110
CryoFlex Surgical Ablation System – Non-Paroxysmal Atrial Fibrillation – Product Status 111
CryoFlex Surgical Ablation System – Non-Paroxysmal Atrial Fibrillation – Product Description 111
PulseSelect PFA System – Product Status 111
PulseSelect PFA System – Product Description 112
Medtronic Plc – Ongoing Clinical Trials Overview 113
Cardioblate Irrigated RF (IRF) System – Non-Paroxysmal Atrial Fibrillation – Irrigated Radio Frequency Ablation to Terminate Non-paroxysmal Atrial Fibrillation: Terminate AF Study 114
PulseSelect PFA System – A Study to Evaluate the Efficacy of Pulsed Field Ablation Treatment in Subjects with Atrial Fibrillation 115
National Science and Technology Development Agency Pipeline Products & Ongoing Clinical Trials Overview 116
Cardiac Ablation Device – Product Status 116
Cardiac Ablation Device – Product Description 116
Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 117
Cardiac Tissue Ablation Device – Product Status 117
Cardiac Tissue Ablation Device – Product Description 117
Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 118
Caldus – Renal Denervation – Product Status 118
Caldus – Renal Denervation – Product Description 118
Caldus – Traditional Tissue Ablation – Product Status 119
Caldus – Traditional Tissue Ablation – Product Description 119
Pulse Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 120
Cardiac Ablation Catheter – Product Status 120
Cardiac Ablation Catheter – Product Description 120
CellFX nsPFA Cardiac Clamp – Product Status 121
CellFX nsPFA Cardiac Clamp – Product Description 121
Pulse Biosciences Inc – Ongoing Clinical Trials Overview 122
Cardiac Ablation Catheter – A First-In-Human Feasibility Study to Evaluate Efficacy of CellFX Nanosecond Pulsed Field (nsPFA) Technology in the Treatment of Atrial Fibrillation 123
Cardiac Ablation Catheter – A First-in-human Study of Nanosecond Pulsed Field Ablation (nsPFA) Cardiac Catheter on the Treatment of Atrial Fibrillation 123
Shanghai Antec Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 124
Cryoballoon Ablation System – Product Status 124
Cryoballoon Ablation System – Product Description 124
Pulsed Electric Field Ablation System – Product Status 124
Pulsed Electric Field Ablation System – Product Description 125
Shanghai Hantong Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 126
Next-Generation Ultrasound Ablation System – Heart Failure – Product Status 126
Next-Generation Ultrasound Ablation System – Heart Failure – Product Description 126
Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 127
Cryoablation Device – Product Status 127
Cryoablation Device – Product Description 127
Shanghai Keku Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 128
Cardiac Ablation Device – Atrial Fibrillation – Product Status 128
Cardiac Ablation Device – Atrial Fibrillation – Product Description 128
Shanghai Ruidao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 129
Irreversible Electroporation Ablation Device – Atrial Fibrillation – Product Status 129
Irreversible Electroporation Ablation Device – Atrial Fibrillation – Product Description 129
Shanghai Weiqi Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 130
Cardiac Cryoablation System – Product Status 130
Cardiac Cryoablation System – Product Description 130
Shanghai Weiqi Medical Equipment Co Ltd – Ongoing Clinical Trials Overview 131
Cardiac Cryoablation System – A Prospective, Multicenter, Single-arm Clinical Trial Evaluating the Safety and Efficacy of a Cardiac Cryoablation System for the Treatment of Paroxysmal Atrial Fibrillation 132
Shanghai Xuanyu Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 133
Multi-Channel Pulsed Electric Field Ablation Instrument – Product Status 133
Multi-Channel Pulsed Electric Field Ablation Instrument – Product Description 133
Shenzhen Huitai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 134
Cardiac Pulse Electric Field Ablation System – Product Status 134
Cardiac Pulse Electric Field Ablation System – Product Description 134
Shenzhen Maiwei Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 135
Nanosecond Pulsed Electric Field Ablation (nsPFA) Device – Product Status 135
Nanosecond Pulsed Electric Field Ablation (nsPFA) Device – Product Description 135
Sichuan Jinjiang Electronic Science and Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136
Cardiac Ablation System – Product Status 136
Cardiac Ablation System – Product Description 136
SIGT LLC Pipeline Products & Ongoing Clinical Trials Overview 137
Pulsed Field Ablation and Lesion Assessment System – Product Status 137
Pulsed Field Ablation and Lesion Assessment System – Product Description 137
Suzhou Aikemai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 138
PFA Pulsed Electric Field Ablation System – Atrial Fibrillation – Product Status 138
PFA Pulsed Electric Field Ablation System – Atrial Fibrillation – Product Description 138
PFA Pulsed Electric Field Ablation System – Premature Ventricular Contraction – Product Status 138
PFA Pulsed Electric Field Ablation System – Premature Ventricular Contraction – Product Description 139
Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 140
Tira Catheter – Product Status 140
Tira Catheter – Product Description 140
Tau Pnu Medical Co., Ltd. – Ongoing Clinical Trials Overview 141
Tira Catheter – A Multicenter, Open, Single Design, Researcher-led, Phase 1 Exploratory Study to Evaluate the Safety and Efficacy of Vein of Marshall RF Ablation Using TIRA(VA510 and Other 3 Types) in Patients with Persistent Atrial Fibrillation 142
Tira Catheter – The Study for Evaluation of Safety and Efficacy of Transcatheter RF Ablation System (TIRA Catheter) to Treat Hypertrophic Obstructive Cardiomyopathy: Multi-center, Open Label, Single Arm, Investigator Initiated Exploratory Pilot Study 142
The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 143
Transcatheter Septal Myectomy Device – Product Status 143
Transcatheter Septal Myectomy Device – Product Description 143
Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 144
Durablate Ablation Catheter – Product Status 144
Durablate Ablation Catheter – Product Description 144
SERF Ablation System – Ventricular Tachycardia – Product Status 145
SERF Ablation System – Ventricular Tachycardia – Product Description 145
Thermedical Inc – Ongoing Clinical Trials Overview 146
SERF Ablation System – Ventricular Tachycardia – Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT 147
Tianjin Intelligent Health Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 148
Pulsed-Field Ablation System – Paroxysmal Atrial Fibrillation – Product Status 148
Pulsed-Field Ablation System – Paroxysmal Atrial Fibrillation – Product Description 148
Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 149
Satake HotBalloon Catheter – Product Status 149
Satake HotBalloon Catheter – Product Description 149
Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 150
Tissue Ablation Device – Product Status 150
Tissue Ablation Device – Product Description 150
University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 151
Cryogenic Anchor – Product Status 151
Cryogenic Anchor – Product Description 151
University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 152
DVT Histotripsy System – Product Status 152
DVT Histotripsy System – Product Description 152
University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 153
Sheath Delivery System – Atrioventricular Nodal Ablation – Product Status 153
Sheath Delivery System – Atrioventricular Nodal Ablation – Product Description 153
Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 154
Cardiac Radioablation System – Product Status 154
Cardiac Radioablation System – Product Description 154
Varian Medical Systems Inc – Ongoing Clinical Trials Overview 155
Cardiac Radioablation System – Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia 156
Virginia Polytechnic Institute and State University Pipeline Products & Ongoing Clinical Trials Overview 157
Irreversible Electroporation Ablation System – Product Status 157
Irreversible Electroporation Ablation System – Product Description 157
VytronUS Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 158
Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System – Product Status 158
Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System – Product Description 158
VytronUS Inc (Inactive) – Ongoing Clinical Trials Overview 159
Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System – Early Feasibility Study of Automated Ultrasound Technology for the Treatment of Persistent Atrial Fibrillation 160
Glossary 203
